Find clinical trials for Acute Myeloid Leukemia (AML) in Orlando, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Orlando, FL, USA:
to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...
Phase 2
Orlando, Florida, United States and 57 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Orlando, Florida, United States and 85 other locations
to placebo and VEN+AZA alone for the treatment of participants with Acute Myeloid Leukemia (AML) with a mutation ...
Phase 3
Orlando, Florida, United States and 169 other locations
which contains populations of CD8+ T cells targeting multiple leukemia associated antigen peptides in patients with Acute Myeloid...
Phase 1, Phase 2
Orlando, Florida, United States and 4 other locations
). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....
Phase 2
Orlando, Florida, United States and 32 other locations
combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...
Phase 3
Kissimmee, Florida, United States and 275 other locations
with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...
Phase 1
Orlando, Florida, United States and 36 other locations
drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to vene...
Phase 2
Orlando, Florida, United States and 30 other locations
A treatment cycle is 28 days for Cycle 1 and Cycle 2. Tagraxofusp will be administered at 12 mcg/kg IV over 15 minutes (-5 or +15 minutes) daily for...
Phase 2
Orlando, Florida, United States and 5 other locations
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior in...
Phase 3
Orlando, Florida, United States and 38 other locations
Clinical trials
Research sites
Resources
Legal